Steffen Hackbarth Selected Research

Steffen Hackbarth Research Topics

8	Neoplasms (Cancer) 05/2022 - 11/2012
2	Phototoxic Dermatitis (Phototoxicity) 02/2011 - 07/2009
1	Photosensitivity Disorders (Photodermatitis) 05/2022
1	Hypoxia (Hypoxemia) 06/2019
1	Lung Neoplasms (Lung Cancer) 09/2018
1	Skin Neoplasms (Skin Cancer) 01/2015
1	Atopic Dermatitis (Atopic Eczema) 08/2012
1	Eczema 08/2012
1	Breast Neoplasms (Breast Cancer) 02/2007

5	Photosensitizing Agents (Photosensitizers)IBA 05/2022 - 06/2016
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2019 - 11/2012
4	Singlet OxygenIBA 05/2022 - 11/2012
2	Oxygen (Dioxygen)IBA 05/2022 - 06/2019
2	pyropheophorbide aIBA 06/2019 - 09/2018
2	Pharmaceutical PreparationsIBA 06/2019 - 02/2013
2	Dendrimers (Dendrons)IBA 06/2016 - 12/2015
1	N-(2-hydroxypropyl)methacrylamideIBA 06/2019
1	DuxonIBA 09/2018
1	XenonIBA 09/2018
1	phytochlorinIBA 06/2016
1	AntioxidantsIBA 01/2015
1	chlorinIBA 02/2013
1	CosmeticsIBA 08/2012
1	temoporfinIBA 02/2011
1	pheophorbide aIBA 07/2009
1	AcidsIBA 02/2007
1	Acetylcysteine (Siran)FDA LinkGeneric 02/2007
1	cadmium selenideIBA 02/2007
1	Cysteamine (Mercaptamine)FDA Link 02/2007
1	zinc sulfideIBA 02/2007
1	cadmium tellurideIBA 02/2007

3	Photochemotherapy (Photodynamic Therapy) 09/2018 - 11/2012
1	Precision Medicine 09/2018
1	Endoscopes 09/2018
1	Intravenous Injections 06/2016
1	Subcutaneous Injections 06/2016
1	Therapeutics 02/2013